Cowen Downgrades Corcept Therapeutics (CORT) to Neutral
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $22.66 --0%
Rating Summary:
7 Buy, 8 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 16 | New: 16
Rating Summary:
7 Buy, 8 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 16 | New: 16
Join SI Premium – FREE
Cowen downgraded Corcept Therapeutics (NASDAQ: CORT) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $1.58 yesterday.
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $1.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- HSBC Downgrades Harmony Gold Mining (HAR:SJ) (HMY) to Reduce
- HSBC Downgrades Infosys Technologies (INFY) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
